NORWALK,Conn.,Feb. 26,2025-- Emeren Group Ltd ("Emeren" or the "Company") (www.emeren.com) (NYSE: SOL),a leading global solar project developer,owner,and operator,today announced
Feb 27, 2025
Insights hub provides fuel,idling and emissions trends to reduce waste and cut costs,improve performance.
Feb 27, 2025
- Showcased core technology and products for personalized tDCS at the conference in Kobe,Japan - Presented clinical outcomes in disorders of consciousness,upper extremity function in patients with su
Feb 27, 2025
BEIJING,Feb. 27,2025--At the 2025 Automotive Supply Chain New Ecology Conference,organized by China Automotive News under the guidance of China Energy & Automotive Media Group Ltd.,DEKRA was reco
Feb 27, 2025
PERTH,Australia,Feb. 27,2025-- Neopharma Technologies Ltd (Neopharma) is pleased to announce a strategic partnership with AusChain Pty Ltd,a global leader in scalable blockchain solutions specializing
Feb 27, 2025
HONG KONG,Feb. 27,2025-- Tencent Cloud,the cloud business of global leading technologycompany Tencent,has been named as a leader among cloud platforms for games in the latest report by Omdia,a premier
Feb 27, 2025
Newly Patented Technology Improves Policy Research and Compliance Monitoring CODIT Enhances Legislative Intelligence Offerings with U.S. Patent Recognition
Feb 27, 2025
TRIESEN,Liechtenstein,Feb. 25,2025-- Following the success of last year\'s EdHeroes Global Forum on Cultural Heritage in Education,the global education network EdHeroes introduces a fresh new initiati
Feb 26, 2025
NETSCOUT\'s solutions provide actionable intelligence through powerful deep packet inspection,behavioral analytics,and AI-driven insights
Feb 26, 2025
ASUS will unveil its latest advancements in AI infrastructure from AI servers to edge AI solutions for diverse enterprise needs
Feb 26, 2025
SINGAPORE,Feb. 25,2025-- ADA,a leader in data and AI-driven digital transformation and all-in-one authentication solutions,and IPification,a pioneer in seamless mobile authentication,have announced t
Feb 26, 2025
Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem
Feb 26, 2025

© Voice Of Zimbabwe Privacy Policy Contact us